Thompson Siegel & Walmsley’s DaVita DVA Stock Holding History
Bought
Maintained
Sold
Other funds holding DVA
GCM
Thompson Siegel & Walmsley's DVA Position: Q2 2021 in Review
Thompson Siegel & Walmsley sold out of DaVita (DVA) in Q2 2021, closing a stake of 6 shares — an estimated $1K sold.
Thompson Siegel & Walmsley first reported a position in DVA in Q3 2013 and held it in 15 quarters. The position peaked at $43.5M in Q2 2019. 515 funds tracked by Wall St. Rank hold DVA as of Q2 2021.
- Thompson Siegel & Walmsley reported no remaining DaVita position as of Q2 2021 after selling out during the quarter.
- Thompson Siegel & Walmsley sold 6 DaVita shares in Q2 2021, an estimated $1K.
- Thompson Siegel & Walmsley first reported a position in DaVita in Q3 2013 and held it in 15 quarters.
- Thompson Siegel & Walmsley's DaVita position peaked at $43.5M in Q2 2019.
- 515 funds tracked by Wall St. Rank held DaVita as of Q2 2021.
Based on Thompson Siegel & Walmsley's 13F filing for Q2 2021, filed 9 Aug 2021.